Statement on the safety of d‐ribose
Bioenergy Life Science, Inc. Type: Statement ...
Ergebnisse durchsuchen
Ergebnisse 1 - 10 von 18
Statement on the safety of taxifolin-rich extract from Dahurian Larch (Larix gmelinii)
European Commission following the provision of additional information by Ametix JSC Type: Statement ...
Statement on the safety of synthetic l-ergothioneine as a novel food – supplementary dietary exposure and safety assessment for infants and young children, pregnant and breastfeeding women
nda@efsa.europa.eu On request from: European Commission Type: Statement ...
Statement on the safety of EstroG-100™ as a novel food pursuant to Regulation (EC) No 258/97
Commission following the provision of additional information by Naturalendo Tech Co., Ltd Type: Statement ...
Urgent advice on lumpy skin disease
29 July 2016 Contact: alpha@efsa.europa.eu On request from: European Commission Type: Statement ...
Safety of ‘Cetyl Myristoleate Complex’
nda@efsa.europa.eu On request from: European Commission Type: Statement ...
Conceptual framework for bovine tuberculosis
interact in various European situations. The conceptual framework on bTB described in this statement is ... 2014 Contact: alpha@efsa.europa.eu On request from: EFSA Type: Statement ...
Safety of Cetyl Myristoleate Complex
Statement ...
Safety of “conjugated linoleic acid (CLA) rich oils”
Statement ...
Safety of glucosamine for patients receiving coumarin anticoagulants
Allergies to provide a scientific statement on the safety of glucosamine for patients receiving coumarin ... 25 November 2011 Contact: nda@efsa.europa.eu On request from: EFSA Type: Statement ...